NCT07396636

Brief Summary

Intraoperative hypotension, defined as a drop in blood pressure during surgery, is a frequent event in patients undergoing general anesthesia. Even brief episodes of low blood pressure may reduce blood flow to vital organs such as the brain, heart, and kidneys, and have been associated with an increased risk of postoperative complications, prolonged recovery, and worse clinical outcomes. Despite its clinical importance, the management of intraoperative hypotension is often based on general guidelines and individual clinician experience rather than patient-specific physiological mechanisms. Low blood pressure during surgery can occur for different underlying reasons, including reduced circulating blood volume, excessive vasodilation caused by anesthetic agents, impaired heart contractility, or abnormalities in heart rate. In routine practice, these mechanisms are not always clearly distinguished, and similar treatment strategies may be applied to patients with different physiological causes of hypotension. As a result, the response to treatment can vary widely between patients. This prospective observational study aims to improve the understanding of intraoperative hypotension by collecting detailed hemodynamic data during surgery and analyzing these data using machine learning methods. The study is designed to observe current clinical practice without altering or interfering with routine patient care. All decisions regarding anesthesia management and treatment of hypotension will be made by the attending anesthesiologists according to standard clinical practice. The research team will not provide treatment recommendations during surgery. Adult patients undergoing elective surgery under general anesthesia with continuous invasive arterial blood pressure monitoring will be included. During the intraoperative period, blood pressure, heart rate, cardiac output, stroke volume, systemic vascular resistance, and other advanced hemodynamic parameters will be continuously recorded at regular intervals. When hypotension occurs, the onset, duration, and severity of the episode will be documented, along with the treatment applied, such as fluid administration, vasopressor agents, or inotropic medications. The time required for blood pressure to recover to an acceptable level will also be recorded. The collected data will be analyzed using machine learning techniques to identify distinct subtypes of intraoperative hypotension based on physiological patterns. These subtypes may reflect different underlying mechanisms, such as hypovolemia, vasodilation, myocardial depression, or heart rate-related causes. In addition, the study will evaluate how different treatment strategies perform across these hypotension subtypes and how quickly hemodynamic stability is restored. Patient-related factors such as age, sex, body mass index, physical status classification, and comorbid conditions will also be examined to determine their relationship with the occurrence, severity, and treatment response of hypotension episodes. By combining patient characteristics, physiological data, and treatment responses, the study aims to generate data-driven insights into personalized hypotension management. The ultimate goal of this research is to support the development of individualized treatment recommendations for intraoperative hypotension based on objective physiological data rather than a one-size-fits-all approach. The findings of this study are expected to provide a strong scientific foundation for future clinical decision-support systems that can assist anesthesiologists in selecting the most appropriate treatment strategy for each patient. By improving the precision of blood pressure management during surgery, this approach has the potential to enhance patient safety and perioperative outcomes while maintaining standard clinical workflows.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Mar 2026Sep 2026

First Submitted

Initial submission to the registry

January 30, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 9, 2026

Completed
22 days until next milestone

Study Start

First participant enrolled

March 3, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

January 30, 2026

Last Update Submit

April 6, 2026

Conditions

Keywords

Intraoperative hypotensionMachine learningPersonalized treatmentClinical decision supportHemodynamic instability

Outcome Measures

Primary Outcomes (1)

  • Intraoperative hypotension endotype classification (hemodynamic subtype) per hypotension episode

    For each intraoperative hypotension episode (defined as mean arterial pressure \[MAP\] \<65 mmHg lasting ≥1 minute, or a ≥30% decrease from baseline), the episode will be assigned to a hemodynamic endotype based on invasive arterial waveform-derived parameters recorded using MostCare® (Vygon, France), including MAP, SAP, DAP, HR, CO, CI, SV, SVI, SVR, SVRI, SVV, PPV, and SPV, sampled every 30 seconds. The outcome is the endotype label assigned to each episode, reported as a categorical classification with the following levels: Hypovolemic endotype, Vasodilatory endotype, Myocardial depression endotype and Bradycardic endotype.

    Intraoperative period (from anesthesia induction to the end of surgery)

Secondary Outcomes (3)

  • Time to hemodynamic stabilization after treatment of intraoperative hypotension

    Intraoperative period (from anesthesia induction to the end of surgery)

  • Correlation between patient characteristics and intraoperative hypotension burden

    Intraoperative period (from anesthesia induction to the end of surgery)

  • Performance of AI-based personalized hypotension treatment recommendation model

    Intraoperative period (from anesthesia induction to the end of surgery)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will be drawn from adult patients undergoing elective surgical procedures under general anesthesia at a tertiary care hospital. Participants will be selected from operating rooms where continuous invasive arterial blood pressure monitoring is routinely used as part of standard anesthetic care. The study will include patients managed according to usual clinical practice by attending anesthesiologists, without any protocol-driven intervention. Data will be collected prospectively during the intraoperative period from routine monitoring systems and anesthesia records. The population reflects a real-world perioperative setting in which intraoperative hypotension is commonly encountered and managed using standard hemodynamic monitoring and treatment strategies.

You may qualify if:

  • Adult patients aged 18 years or older
  • Patients scheduled for elective surgical procedures
  • Procedures performed under general anesthesia
  • Availability of continuous invasive arterial blood pressure monitoring during the intraoperative period
  • Planned surgical duration of at least 2 hours
  • Ability to provide written informed consent for participation in the study

You may not qualify if:

  • Emergency surgery
  • Diagnosis of sepsis, septic shock, or advanced cardiogenic shock
  • Cardiac rhythm disturbances that prevent reliable hemodynamic measurements (e.g., atrial fibrillation)
  • Severe left ventricular dysfunction or advanced heart failure (ejection fraction \<30%)
  • Inability to maintain intraoperative arterial cannulation due to technical or clinical reasons
  • Inability to provide informed consent (e.g., cognitive impairment or refusal to participate)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konya City Hospital

Konya, Konya/Meram, 42040, Turkey (Türkiye)

RECRUITING

Study Officials

  • Mehmet Akif Yazar, MD, PhD, Assoc. Prof

    Konya City Hospital

    STUDY DIRECTOR

Central Study Contacts

Mehmet Akif Yazar, MD, PhD, Assoc. Prof.

CONTACT

Elif Korkmaz Ozturk, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 30, 2026

First Posted

February 9, 2026

Study Start

March 3, 2026

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

April 9, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared with other researchers due to the nature of high-resolution intraoperative hemodynamic data and institutional data governance policies. All analyses will be conducted on anonymized datasets within the research team, and only aggregate results will be reported.

Locations